Dark
Light
System
Institutional Investment Manager
ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC (CIK: 0001055951) incorporated in Delaware, located at 601 Lexington Avenue, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2017Q1)
Portfolio Summary: 136 holdings with a total value of $8,822,204,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ALEXION PHARMACEUTIC 3,710,986 449,920,000 5.10%
2 BIOGEN INC 1,436,900 392,877,000 4.45%
3 CELGENE CORP 3,132,177 389,737,000 4.42%
4 BOSTON SCIENTIFIC CORP 15,311,400 380,795,000 4.32%
5 MERCK & CO INC 5,714,900 363,125,000 4.12%
6 LILLY ELI & CO 3,330,200 280,103,000 3.17%
7 Wright Medical Group NV 8,946,234 278,407,000 3.16%
8 INCYTE CORP 1,973,597 263,811,000 2.99%
9 VERTEX PHARMACEUTICALS INC 2,169,200 237,202,000 2.69%
10 AMGEN INC 1,438,300 235,982,000 2.67%
11 AGILENT TECHNOLOGIES INC 3,629,900 191,913,000 2.18%
12 PFIZER INC 5,406,100 184,943,000 2.10%
13 EDWARDS LIFESCIENCES CORP 1,839,300 173,023,000 1.96%
14 AETNA INC NEW 1,312,400 167,397,000 1.90%
15 SHIRE PLC 897,451 156,363,000 1.77%
16 HCA HOLDINGS INC 1,745,000 155,288,000 1.76%
17 HUMANA INC 742,300 153,018,000 1.73%
18 REGENERON PHARMACEUTICALS 378,170 146,545,000 1.66%
19 ANTHEM INC 862,600 142,657,000 1.62%
20 ABBVIE INC 2,080,000 135,533,000 1.54%
21 ARRAY BIOPHARMA INC 14,182,900 126,795,000 1.44%
22 IRONWOOD PHARMACEUTICALS INC 7,241,300 123,537,000 1.40%
23 CENTENE CORP DEL 1,655,700 117,985,000 1.34%
24 INTERCEPT PHARMACEUTICALS INCORPORATED 1,037,000 117,285,000 1.33%
25 ALLERGAN PLC 477,390 114,058,000 1.29%
26 BIOMARIN PHARMACEUTICAL INC 1,274,100 111,840,000 1.27%
27 CORVUS PHARMACEUTICALS INC COM 5,379,349 111,729,000 1.27%
28 JOHNSON & JOHNSON 884,600 110,177,000 1.25%
29 BRISTOL MYERS SQUIBB CO 1,911,000 103,920,000 1.18%
30 SYNERGY PHARMACEUTICALS DEL 21,153,343 98,575,000 1.12%
31 TENET HEALTHCARE CORP 5,352,000 94,784,000 1.07%
32 GLAUKOS CORP 1,741,700 89,349,000 1.01%
33 INSMED INC 4,810,905 84,239,000 0.95%
34 PUMA BIOTECHNOLOGY 2,245,925 83,548,000 0.95%
35 THERMO FISHER SCIENTIFIC INC 534,200 82,053,000 0.93%
36 Audentes Therapeutics, Inc. 4,801,638 81,820,000 0.93%
37 VIEWRAY INC COM USD0.01 9,458,567 80,492,000 0.91%
38 Ascendis Pharma 2,717,315 76,085,000 0.86%
39 MAGELLAN HEALTH INC COM NEW 1,088,727 75,177,000 0.85%
40 ALLERGAN PLC 88,200 74,832,000 0.85%
41 LOXO ONCOLOGY INC COM 1,728,000 72,714,000 0.82%
42 AERIE PHARMACEUTICALS INC COM 1,496,000 67,844,000 0.77%
43 MALLINCKRODT PUB LTD CO 1,472,700 65,638,000 0.74%
44 INSYS THERAPEUTICS INC NEW COM NEW 6,071,440 63,811,000 0.72%
45 MEDTRONIC PLC 766,600 61,757,000 0.70%
46 GW PHARMACEUTICALS PLC 475,900 57,555,000 0.65%
47 EAGLE PHARMACEUTICALS INC COM 671,000 55,653,000 0.63%
48 ACHILLION PHARMACEUTICALS IN 13,107,200 55,181,000 0.63%
49 ILLUMINA INC 321,900 54,929,000 0.62%
50 GILEAD SCIENCES INC 800,900 54,397,000 0.62%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-001216, filed 2017.05.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.